Announcements Trials

Browse Landscape

Phase

Status

Recruiting 34 Active not recruiting 34 Completed 17 Not yet recruiting 5 Terminated 3 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Carcinoma In Situ 1

Interventions

Specimen Handling 35 Magnetic Resonance Spectroscopy 23 Biopsy 22 Cyclophosphamide 11 venetoclax 7 Nivolumab 6 Azacitidine 6 pembrolizumab 5 Taxes 5 Etoposide 5 Cisplatin 5 Bevacizumab 5 fludarabine phosphate 4 fludarabine 4 X-Rays 4 Vincristine 4 Surgical Procedures, Operative 4 Radiosurgery 4 Radiation 4 Gemcitabine 4 Doxorubicin 4 Cetuximab 4 130-nm albumin-bound paclitaxel 4 durvalumab 3 decitabine and cedazuridine drug combination 3 cemiplimab 3 Tacrolimus 3 Surveys and Questionnaires 3 Radiotherapy, Intensity-Modulated 3 Prednisone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Anastrozole × 1 year × Clear all

NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡